| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 12/13/2001 | CA2411010A1 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 12/13/2001 | CA2410993A1 Starter kit for low dose oral contraceptives |
| 12/13/2001 | CA2409392A1 Intracellular signaling proteins |
| 12/13/2001 | CA2409268A1 Macromolecular drug complexes and compositions containing the same |
| 12/13/2001 | CA2409123A1 Heterocycle derivatives and methods of use |
| 12/13/2001 | CA2408748A1 Nuclear hormone receptor |
| 12/12/2001 | EP1162265A2 Human PEM as a target for fertility control and Alzheimer therapy |
| 12/12/2001 | EP1161687A1 Grb14 and the insulin receptor and screening of novel medicines |
| 12/12/2001 | EP1161448A1 49 human secreted proteins |
| 12/12/2001 | EP1161447A1 50 human secreted proteins |
| 12/12/2001 | EP1161442A2 Exocytosis pathway proteins and methods of use |
| 12/12/2001 | EP1161431A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 12/12/2001 | EP1161410A1 Retinoid antagonists and use thereof |
| 12/12/2001 | EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
| 12/12/2001 | EP0666758B1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 12/12/2001 | CN1326462A Betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 12/12/2001 | CN1326461A Meiosis regulating compounds |
| 12/12/2001 | CN1326457A 4-aminopyrrolopyrimidines as kinase inhibitors |
| 12/12/2001 | CN1326456A 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives |
| 12/12/2001 | CN1326359A Human chorionic gonadotropin vaccines |
| 12/12/2001 | CN1326353A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 12/12/2001 | CN1326347A 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens |
| 12/12/2001 | CN1326344A PUFA supplements |
| 12/12/2001 | CN1326343A Agent for lowering prolactin |
| 12/12/2001 | CN1326337A Drug delivery device, especially for delivery of progestins and estrogens |
| 12/12/2001 | CN1326322A Method for supplying bioavailable methionine to cow |
| 12/12/2001 | CN1325719A Antalgesic liquid for cervical dilatation |
| 12/12/2001 | CN1325716A Pharmacotherapeutic food for preventing and curing woman climacteric syndrome |
| 12/12/2001 | CN1325696A Breast pill or ointment for treating mastopathy and preparing process thereof |
| 12/11/2001 | US6329520 Used as imaging or pharmaceutical agents, in the diagnosis and treatment of drug addiction, depression, anorexia and neurodegenerative diseases or in determining doses of therapeutic agents that occupy many receptors |
| 12/11/2001 | US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 12/11/2001 | US6329416 Administering to female of child bearing age for 28 consecutive days: first phase dosage of progestational agent; second phase of antiprogesin compound, and third phase of placebo for contraception |
| 12/11/2001 | US6329388 Thienopyridine compounds, their production and use |
| 12/11/2001 | US6328966 Transferrin compositions to alleviate the side effects of cytotoxic drugs |
| 12/11/2001 | CA2226292C Substituted benzolactam compounds as substance p antagonists |
| 12/06/2001 | WO2001092892A2 Methods to identify compounds that modulate rage |
| 12/06/2001 | WO2001092581A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | WO2001092527A2 Regulators of apoptosis |
| 12/06/2001 | WO2001092308A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | WO2001092267A2 Dihydropyridine compounds for the inhibition of calcium-influx |
| 12/06/2001 | WO2001092230A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 12/06/2001 | WO2001092224A1 Indole derivatives with vascular damaging activity |
| 12/06/2001 | WO2001092221A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 12/06/2001 | WO2001092210A1 Compounds for modulating the rage receptor |
| 12/06/2001 | WO2001092202A1 Il-8 receptor antagonists |
| 12/06/2001 | WO2001091787A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | WO2001091752A1 Melanocortin receptor agonists |
| 12/06/2001 | WO2001091744A1 Methods of treating androgen deficiency in men using selective antiestrogens |
| 12/06/2001 | WO2001049673A3 Compounds and methods for modulation of estrogen receptors |
| 12/06/2001 | WO2001041704A3 Method for the prevention and/or treatment of atherosclerosis |
| 12/06/2001 | WO2001024788A3 Treating endometriosis or infertility, or improving fertility |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | WO2001007021A3 Process for the improvement of spermatozoa fertilization activity |
| 12/06/2001 | WO2000077018A3 Purine derivatives |
| 12/06/2001 | US20010049360 Betaglycan as an inhibin receptor and uses thereof |
| 12/06/2001 | US20010049106 ADAM (A Disintegrin And Metalloprotease) family of metalloproteases, and in addition contain thrombospondin domain (TS); treating diabetes, arthritis, cancer, solid tumors, autoimmune diseases |
| 12/06/2001 | CA2599562A1 Compounds for modulating the rage receptor |
| 12/06/2001 | CA2411404A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | CA2411323A1 Il-8 receptor antagonists |
| 12/06/2001 | CA2410912A1 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | CA2410903A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | CA2410655A1 Dihydropyridine compounds for the inhibition of calcium-influx |
| 12/06/2001 | CA2410597A1 Melanocortin receptor agonists |
| 12/06/2001 | CA2409311A1 Regulators of apoptosis |
| 12/06/2001 | CA2406979A1 Indole derivatives with vascular damaging activity |
| 12/05/2001 | EP1160323A1 5T4 tumour-associated antigen for use in tumour immunotherapy |
| 12/05/2001 | EP1160254A1 Human vanilloid receptor-like proteins |
| 12/05/2001 | EP1160248A1 N-(Isoxazol-5-yl)-sulfonamide derivatives and their use as endothelin antagonists |
| 12/05/2001 | EP1159965A2 Method of preventing or inhibiting fertilization |
| 12/05/2001 | EP1159445A1 Method to search for male antifertility drugs based on phgpx activity determination |
| 12/05/2001 | EP1159291A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 12/05/2001 | EP1159284A1 33 human secreted proteins |
| 12/05/2001 | EP1159265A1 C-16 unsaturated fp-selective prostaglandins analogs |
| 12/05/2001 | EP1159009A2 Use of niaouli essential oil as transdermal permeation enhancer |
| 12/05/2001 | EP1158996A1 Novel amide derivatives as growth hormone secretagogues |
| 12/05/2001 | EP1158978A1 Medicament against dysmenorrhoea and premenstrual syndrome |
| 12/05/2001 | EP1158958A1 Improved powdery pharmaceutical compositions for inhalation |
| 12/05/2001 | EP1026947B1 Composition and method for treating penile erectile dysfunction |
| 12/05/2001 | EP0868187B1 Transdermal estradiol/progestogen agent patch and its production |
| 12/05/2001 | EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors |
| 12/05/2001 | EP0814800B1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 12/05/2001 | CN1325399A Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
| 12/05/2001 | CN1325398A Pyrazolopyrimidinone derivatives for the treatment of impotence |
| 12/05/2001 | CN1325389A 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/05/2001 | CN1324659A Vagina spry containing biological active factor |
| 12/05/2001 | CN1324658A Vagina spray with repair function |
| 12/05/2001 | CN1324654A Cold eliminating pellet |
| 12/05/2001 | CN1324638A External-use medicine for treating vaginitis |
| 12/04/2001 | US6326379 Fused pyridine inhibitors of cGMP phosphodiesterase |
| 12/04/2001 | US6326378 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 12/04/2001 | US6326359 Adenosine A2A receptor agonists as antiinflammatory agents |
| 12/04/2001 | US6326352 Compounds and methods for modulating cell adhesion |
| 12/04/2001 | US6326181 Cell volume-regulated human kinase h-sgk |
| 12/04/2001 | CA2218452C Novel ligands of the neuropeptide receptor hfgan72 |
| 12/04/2001 | CA2040914C Treatment of erectile dysfunction |
| 11/30/2001 | CA2348847A1 New isoxazole-sulfonamide endothelin antagonists |
| 11/29/2001 | WO2001090363A1 Chimeric arterivirus-like particles |
| 11/29/2001 | WO2001090359A2 G-protein coupled receptors |
| 11/29/2001 | WO2001090334A2 Drug metabolizing enzymes |
| 11/29/2001 | WO2001090144A2 Vip-related peptides for the treatment of sexual disorders in women |